Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

US Patent 9249229 · Granted Feb 2, 2016

Estimated economic value: $239,562,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-human animals having an engineered immunoglobulin lambda light chain locus2025
Non-human animals having a humanized a proliferation-inducing ligand gene2025
Mice expressing a limited immunoglobulin light chain repertoire2025
Models of tauopathy2025
Nucleic acids encoding anchor modified antibodies and uses thereof2025
Immunoglobulin lambda light chain and uses thereof2025
Non-human animals expressing exogenous terminal deoxynucleotidyltransferase2025
Models of tauopathy2024
Mouse having a humanized B-cell activating factor gene2024
Nuclease-mediated DNA assembly2024
Models of tauopathy2023
Humanized non-human animals with restricted immunoglobulin heavy chain loci2023